TYPHOID VI POLYSACCHARIDE VACCINE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract, identified as SPE2DP-26-T-4795, is a solicitation issued by the Department of Defense Medical Supply Chain for the procurement of 16 vials of Modified Acellular Typhoid VI Polysaccharide Vaccine. Each vial contains 10 ml and provides 20 doses. The vaccine must be shipped under constant refrigeration between 2 and 8 degrees Celsius and must adhere to Medical Procurement Item Description number 3 and Medical Marking Standard number 1. The product has a non-extendable shelf life of 18 months, with at least 15 months remaining at the time of delivery to the first government activity. The order is designated for delivery to the USS Barry DDG 52 via the fastest traceable means, with a required delivery date of September 2, 2026, and a delivery window of 20 days after order. Inspection and acceptance will occur at the destination. Packaging must comply with DLA packaging requirements and MIL-STD-129, utilizing ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. Quotes for this requirement were due by September 8, 2026.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
